Daiichi Sankyo builds $152M ADC plant in China as Enhertu wins national coverage
In tandem with Enhertu’s inclusion in China’s national insurance program, Daiichi Sankyo is planting a foothold in local production. Daiichi will invest 1.1 billion Chinese yuan ($152 million) to build a new antibody-drug conjugate (ADC) manufacturing …